Advances in the discovery and development of selective heme-displacing IDO1 inhibitors-Reference-Cited by-同舟云学术

Advances in the discovery and development of selective heme-displacing IDO1 inhibitors

Published:2020-06-22 Issue:10 Volume:15 Page:1223-1232
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Sun Lijun¹

Affiliation:

1. Center for Drug Discovery and Translational Research, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2020.1781811

Reference93 articles.

1. Understanding the tumor immune microenvironment (TIME) for effective therapy

2. Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape

3. Fundamental Mechanisms of Immune Checkpoint Blockade Therapy

4. Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies

5. The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Light‐Triggered PROTAC Nanoassemblies for Photodynamic IDO Proteolysis in Cancer Immunotherapy;Advanced Materials;2024-06-29

2. IDO1 Inhibition Promotes Activation of Tumor-intrinsic STAT3 Pathway and Induces Adverse Tumor-protective Effects;The Journal of Immunology;2024-02-23

3. The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma;OncoImmunology;2023-01-26

4. The promise of targeting heme and mitochondrial respiration in normalizing tumor microenvironment and potentiating immunotherapy;Frontiers in Oncology;2023-01-04

5. An updated patent review of IDO1 inhibitors for cancer (2018–2022);Expert Opinion on Therapeutic Patents;2022-11-02